Treatment of pembrolizumab and chemotherapy results in pulmonary lymphoepithelioma-like carcinoma progression through harboring secondary amplification of PI3KCA and IL-7R. (June 2020) - Chen, Mei-ting; Wang, Zhao; Yuan, Meng; Fang, Xiao-jie; Lin, Tong-yu